Espresso Shot of the Day - Gland Pharma Ltd up by 20.00 percent

EspressoLogy

Espresso Shot of the Day - Gland Pharma Ltd up by 20.00 percent

August 09, 2023
Espresso Shot of the Day - Gland Pharma Ltd up by 20.00 percent

Gland Pharma Ltd. 1612.60 (+20.00%) BSE – INE068V01023| 18th September 2023

ESDGlandPharma_HAL-202308090217421726405.jpg

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We have a professional management team and one of our Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major.

Recent Drivers

  • On July 10th,2023 The U.S. Food and Drug Administration approved Gland Pharma Ltd. new drug application for Fomepizole injectable. Fomepizole injection is an antidote for ethylene glycol such as antifreeze, or methanol poisoning.
  • On July 31st, 2023, 2023, Glen Pharma Ltd received a zero-observation certificate from the US drug regulator for its Visakhapatnam facility. The United States Food and Drug Administration (US FDA) conducted the good manufacturing practice (GMP) inspection at the company’s VSEZ Sterile Oncology facility at Visakhapatnam between July 20 and July 28. The inspection concluded with zero 483 observations and a classification of No Action Indicated (NAI).
  • On May August 7th, 2023 Revenue rose 41% to Rs 1,209 crore
  • As on August 7th, 2023, Operating profit rose 9% to Rs 294 crore.
(Sources: bloomberg, Exchange, Money control)­

Technical Force*

  • S&P BSE200 month till date loss by 0.75%.
  • 3 months avg. NSE volume: 1,026,113
  • Traded on new 52 Week High value 2,606.00
  • Spurt in Volume by more than 16.37 times
  • Quantity traded: 6,46,752| Deliverable quantity: 3,68,455 (56.97)
  • Stock price jumped by more than 87 % from a one-year low level: 861.50 (May 22nd, 2023)
  • Daily RSI (14) is in overbought territory today.
  • 52-week-high: 2,606.00| 52-week-low: 861.50


Key Pivot (Yearly)

R4

R3

R2

R1

PP/FIB PP

S1

S2

S3

S4

Pivot Point

-

5745.73

4902.87.60

3239.53

2396.67

733.33

-109.53

1772.87

-

Fibonacci Pivot

4902.87

3945.50

3354.04.65

2973.09

2396.67

1820.24

1439.30

847.84

-109.53


Today’s Close

1612.60

SMA

BSE

10 DAY

1327.12

20 DAY

1253.32

50 DAY

1102.32

200 DAY

1373.55


Some Key Ratios (Source: BSE)

Market Cap:  11,155.05 Crores

PE: 30.16

OPM%: 33.32

ROE%:  9.23

Promoters holding%: 57.86

Prev. Close:  1343.85


https://www.myespresso.com/images/espresso_shot_blog_credit_image-202212011811370680578.jpg

The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Espresso Financial Services Pvt. Ltd bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Espresso Financial Services Pvt. Limited is under no obligation to update the information in this document from time-to-time.

Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.